Filter
1310
Text search:
pharmaceutical
policies
Featured
119
359
Language
Document type
631
299
187
82
60
16
12
11
6
3
3
Countries / Regions
62
61
54
41
36
36
33
31
27
23
22
21
20
19
19
19
17
17
16
16
14
14
13
13
12
12
11
10
10
9
9
7
7
7
7
5
5
5
5
4
4
4
4
4
4
4
3
3
3
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
579
69
63
59
31
19
12
Toolboxes
156
103
102
72
69
44
35
32
31
26
23
22
21
19
19
14
11
10
7
5
4
4
3
3
1
The list of emergency medicine has been developed though various consultative meeting and workshops with concerned health professionals and institutions. The medicines in the list should be administered to emergency patients only treated in the health institutions, purchased from legal medicine reta
...
Examination of the business behaviour of Boehringer Ingelheim, Bayer and Baxter in Uganda
Bull World Health Organ 2017;95:594–598
Accessed November, 2017
Therapeutics Information and Pharmacovigilance Centre | TIPC
Mapping Report - Catalonia (Spain).
8–18 December 2015
Pan African Medical Journal 2017;27:215. doi: 10.11604/pamj.2017.27.215.12994
These guidelines for the National Pharmacovigilance and Medicine Information System in Rwanda have been developed to ensure that safe, efficacious and quality medicines are made available to all Rwandans.
